Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Prospective Clinical Study
100%
Adjusted Hazard Ratio
100%
Germline Polymorphism
100%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
100%
Gemcitabine Chemotherapy
100%
Overall Survival
75%
ERCC1
75%
Treatment Response
50%
Progression-free Survival
50%
Cytosine
50%
Genotype
50%
GSTP1
50%
Cytidine Deaminase
50%
T Allele
50%
RECQ1
50%
Chemotherapy
25%
Clinical Outcomes
25%
Cisplatin
25%
Carboplatin
25%
Treatment Efficacy
25%
Clinical Activity
25%
Median Overall Survival
25%
Blood Samples
25%
Peripheral Blood
25%
Thymine
25%
Median Progression-free Survival
25%
Non-platinum
25%
Xeroderma pigmentosum Group A
25%
Homozygous mutant
25%
Glutathione S-transferase
25%
Guanine
25%
Non-small Cell Lung Cancer (NSCLC)
25%
Adenosine Triphosphate
25%
Survival Treatment
25%
DNA Helicase
25%
Leukocytopenia
25%
Polyneuropathy
25%
Partial Treatment
25%
GC Genotype
25%
Heterozygous mutant
25%
Medicine and Dentistry
Allele
100%
Clinical Study
100%
Gemcitabine
100%
Lung Cancer
100%
Chemotherapy
100%
Germ Cell
100%
Overall Survival
57%
Hazard Ratio
57%
Treatment Response
42%
Base Excision Repair
42%
Progression Free Survival
42%
Cytidine Deaminase
28%
Cytosine
28%
Cisplatin
14%
Carboplatin
14%
Adenosine Triphosphate
14%
Xeroderma pigmentosum
14%
Prospective Study
14%
Leukopenia
14%
Glutathione S-Transferase
14%
Guanine
14%
DNA Helicase
14%
Thymine
14%
Polyneuropathy
14%
Adenine
14%
Biochemistry, Genetics and Molecular Biology
Germline
100%
Germ Cell
100%
Allele
100%
Clinical Study
100%
Gemcitabine
100%
Overall Survival
57%
Base Excision Repair
42%
Progression Free Survival
42%
Wild Type
42%
Nucleotide Excision Repair
42%
Genotyping
42%
GSTP1
28%
Cytidine Deaminase
28%
Cytosine
28%
Prospective Study
14%
Cisplatin
14%
Adenine
14%
Adenosine Triphosphate
14%
Xeroderma pigmentosum
14%
Helicase
14%
Glutathione S-Transferase
14%
Guanine
14%
Thymine
14%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Clinical Study
100%
Gemcitabine
100%
Lung Cancer
100%
Overall Survival
80%
Progression Free Survival
60%
Cytosine
40%
Cytidine Deaminase
40%
Carboplatin
20%
Cisplatin
20%
Prospective Study
20%
Leukopenia
20%
Adenosine Triphosphate
20%
Glutathione
20%
Transferase
20%
Guanine
20%
Xeroderma pigmentosum
20%
Thymine
20%
DNA Helicase
20%
Polyneuropathy
20%
Adenine
20%
Immunology and Microbiology
Allele
100%
Germ Cell
100%
Overall Survival
57%
Wild Type
42%
Excision Repair
42%
Progression Free Survival
42%